Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion SocietyIsrael's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.